Multimedia Content
Call for phase 2 clinical trial
CuraVac is ready for a phase 2b demonstration of efficacy with the MG Therapeutic Vaccine CV-MG02 and is looking to complete its financing.
Stephane’s story
How I came to develop and use the Therapeutic Vaccine for Myasthenia Gravis.
Stephane’s story (short)
More than 25 years in less than 50 seconds.
Therapeutic Vaccines Explained
A 3 minute explanation of therapeutic vaccines for autoimmune diseases.
Phase 2b clinical trial (short)
A very brief description of how the phase 2b clinical trial can demonstrate efficacy of our MG Therapeutic Vaccine candidate.
Carlos’ testimony
A patient’s testimony and point of view on our work.
The struggles of living with MG
What it means to live with Myasthenia Gravis and the side effects of the disease and its treatments in 30 seconds.
Self-Trial of the MG Therapeutic Vaccine
Why I decided to test the first version of the MG Therapeutic Vaccine on myself and continue its development for all patients.
Professor Blalock’s revolutionary discovery
How research of a molecular theory lead to therapeutic vaccines for autoimmune diseases.
The story of a discovery and its development
An explanation of the concept of therapeutic vaccines, why they can work in humans, what it means to manufacture a human formulation, and why we are raising funds.
MG Therapeutic Vaccine on to Phase 2b
Why we developed a stronger formulation for the Phase 2b Clinical Trial.
A dog cured of Myasthenia Gravis
